Introduction Weight loss drugs like Ozempic and Wegovy have surged in popularity, revolutionizing the way people approach obesity and diet-related health conditions. But beyond individual weight loss, these drugs are poised to reshape the entire food industry, from grocery shopping trends to dining habits. As these GLP-1 medications gain traction, businesses and policymakers must consider their long-term effects on food consumption, sustainability, and public health. What Is Ozempic? How Does Ozempic Work? Ozempic (semaglutide) is a GLP-1 receptor agonist initially developed for managing type 2 diabetes . It mimics the hormone glucagon-like peptide-1 (GLP-1) , which regulates blood sugar and appetite, helping users feel fuller for longer. Due to its appetite-suppressing properties, Ozempic for weight loss has gained widespread attention. Similarly, Wegovy , another brand of semaglutide , is specifically approved for weight management in individuals struggling with obesity. These...